Usefulness of β blocker therapy in patients with Takayasu arteritis and moderate or severe aortic regurgitation

Japanese Heart Journal

Volumn 41, Issue 3, 2000, Pages 325-337

  Moncada, Gustavo A ^a   Hashimoto, Yuji ^b   Kobayashi, Yasushi ^a   Maruyama, Yoshiaki ^c   Numano, Fujio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KAMEDA MEDICAL CENTER   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic heart failure; Excessive afterload; Left ventricular hypertrophy; Secondary hypertension

Indexed keywords

ACEBUTOLOL; ANTIHYPERTENSIVE AGENT; AROTINOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CELIPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLDOPA; METOPROLOL;

ADULT; AGED; AORTA ARCH SYNDROME; AORTA VALVE REGURGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; ECHOCARDIOGRAPHY; EVALUATION AND FOLLOW UP; FEMALE; HEART AFTERLOAD; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; JAPAN; PRIORITY JOURNAL; SIDE EFFECT; SYMPTOM;

EID: 0033898752     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.41.325     Document Type: Article

References (33)

1. Hashimoto Y, Tanaka M, Hata A, Kakuta T, Maruyama Y, Numano F. Four years follow-up study in patients with Takayasu arteritis and severe aortic regurgitation; assessment by echocardiography. Int J Cardiol 1996; Suppl 54: S173-6.
2. Morooka S, Saito Y, Nonaka Y, Gyotoku Y, Sugimoto T. Clinical features and course of aortitis syndrome in Japanese women older than 40 years. Am J Cardiol 1984; 53: 859-61.
3. Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu's disease). Circulation 1989; 80: 429-37.
4. Hashimoto Y, Numano F, Oniki T, Shimizu S. Left ventricular geometry in Takayasu arteritis complicated by severe aortic regurgitation. Cardiology 1992; 80: 180-3.
5. Sanderson JE, Chan SK, Yip G, et al. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol. J Am Coll Cardiol 1999; 34: 1522-8.
6. Lin JL, Chan HL, Du CC, et al. Long-term beta-blocker therapy improves autonomie nervous regulation in advanced congestive heart failure. Am Heart J 1999; 137: 658-65.
7. Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 1998; 98: 1184-91.
8. Krum H. Beta-blockers in heart failure. The "new wave" of clinical trials [Review]. Drugs 1999; 58: 203-10.
9. Sabbah HN. The cellular and physiologic effects of beta blockers in heart failure [Review]. Clin Cardiol 1999; 22 Suppl 5: V16-20.
10. Van Campen LC, Visser FC, Visser CA. Ejection fraction improvement by beta-blocker treatment in patients with heart failure: an analysis of studies published in the literature [Review]. J Cardiovasc Pharm 1998; 32 Suppl 1: S31-5.
11. Julius S, Valentini M. Consequences of the increased autonomic nervous drive in hypertension, heart failure and diabetes [Review]. Blood Press 1998; Suppl 3: 5-13.
12. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic β-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022-36.
13. Bristow MR. Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents. Am J Cardiol 1993; 71: 12C-22C.
14. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Gross FG, Hjalmarson A. Beneficial effects of Metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in dilated cardiomyopathy (MDC) Trial Study Group. Lancet 1993; 342: 1441-6.
15. Gilbert EM, Olsen SL, Renlud DG, Bristow MR. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. Am J Cardiol 1993; 71: 23C-9C.
16. Anderson B, Hamm C, Persson S, et al. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol 1994; 23: 1397-404.
17. Eichhorn EJ, Heesch CM, Barnett JH, et al. Effect of metoprolol on myocardial function and energetics in patients with non-ischemic dilated cardiomyopathy: a randomized, double blind, placebo-controlled study. J Am Coll Cardiol 1994; 24: 1310-20.
18. Metra M, Nardi M, Giubbini R, Dei Cas L. Effects of short and long-term carvedilol administration on rest and exercise capacity and clinical conditions in patients with idiopatic dilated cardiomyopathy. J Am Coll Cardiol 1994; 24: 1678-87.
19. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with β-adrenergic blockade. J Am Coll Cardiol 1995; 25: 1154-61.
20. Schiller NB, Shah PM, Crawford M, et al. Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcmmitee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
21. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-8.
22. Perry GJ, Helmcke F, Nanda NC, Byard C, Soto B. Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol 1987; 9: 952-9.
23. Bouchard A, Yock P, Schiller NB, et al. Value of color Doppler estimation of regurgitant volume in patients with chronic aortic insufficiency. Am Heart J 1989; 117: 1099-105.
24. Rahko PS. Prevalence of regurgitant murmurs in patients with valvular regurgitation detected by Doppler echocardiography. Ann Intern Med 1989; 111: 466-72.
25. Reynolds T, Abate J, Tenney A, Warner MG. The JH LVOT method in the quantification of aortic regurgitation: How the cardiac sonographer may avoid an important pitfall. J Am Soc Echocardiogr 1991; 4: 105-8.
26. Labovitz AJ, Ferrara RP, Kern MJ, Bryg RJ, Mrosek DG, Williams GA. Quantitative evaluation of aortic insufficency by continuous wave Doppler echocardiography. J Am Coll Cardiol 1986; 8: 1341-7.
27. Grayburn PA, Handshoe R, Smith MD, Harrison MR, DeMaria AN. Quantitative assessment of the hemodynamic consequences of aortic regurgitation by means of continuous wave Doppler recordings. J Am Coll Cardiol 1987; 10: 135-41.
28. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 60: 560-5.
29. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987; 317: 787-92.
30. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 1989; 110: 101-7.
31. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.
32. Hashimoto Y, Numano F, Maruyama Y, et al. Thallium-201 stress scintigraphy in Takayasu arteritis. Am J Cardiol 1991; 67: 879-82.
33. Siburian G, Hashimoto Y, Numano F. Ventricular arrhythmias in Takayasu arteritis. Int J Cardiol 1993; 40: 243-9.